ONYX PHARMACEUTICALS Trademark

Trademark Overview

On Wednesday, November 24, 2010, a trademark application was filed for ONYX PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the ONYX PHARMACEUTICALS trademark a serial number of 85185034. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, August 19, 2014. This trademark is owned by Onyx Pharmaceuticals, Inc.. The ONYX PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

human pharmaceuticals for use in the prevention and treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders
onyx pharmaceuticals

General Information

Serial Number85185034
Word MarkONYX PHARMACEUTICALS
Filing DateWednesday, November 24, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, August 19, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 25, 2011

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICALS"
Description of MarkThe mark consists of two curved lines that partially intersect at one point with the words "ONYX PHARMACEUTICALS" to the right of the curved lines.
Goods and Serviceshuman pharmaceuticals for use in the prevention and treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 30, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOnyx Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameOnyx Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, August 19, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, August 19, 2014ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 20, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 20, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 19, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 18, 2013EXTENSION 4 GRANTED
Thursday, November 14, 2013EXTENSION 4 FILED
Thursday, November 14, 2013TEAS EXTENSION RECEIVED
Tuesday, July 2, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 1, 2013EXTENSION 3 GRANTED
Tuesday, June 4, 2013EXTENSION 3 FILED
Friday, June 28, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 4, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 4, 2013TEAS EXTENSION RECEIVED
Thursday, October 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 25, 2012CORRECTED NOA E-MAILED
Wednesday, October 24, 2012EXTENSION 2 GRANTED
Monday, October 22, 2012EXTENSION 2 FILED
Wednesday, October 24, 2012DIVISIONAL PROCESSING COMPLETE
Monday, October 22, 2012DIVISIONAL REQUEST RECEIVED
Monday, October 22, 2012TEAS REQUEST TO DIVIDE RECEIVED
Monday, October 22, 2012TEAS EXTENSION RECEIVED
Monday, October 22, 2012TEAS STATEMENT OF USE RECEIVED
Thursday, July 12, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 11, 2012EXTENSION 1 GRANTED
Monday, June 18, 2012EXTENSION 1 FILED
Wednesday, July 11, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 18, 2012TEAS EXTENSION RECEIVED
Tuesday, December 20, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 25, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2011PUBLISHED FOR OPPOSITION
Thursday, September 22, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 21, 2011ASSIGNED TO LIE
Thursday, September 8, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 7, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 7, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 7, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 19, 2011APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 19, 2011TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 7, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 7, 2011NON-FINAL ACTION E-MAILED
Monday, March 7, 2011NON-FINAL ACTION WRITTEN
Thursday, March 3, 2011ASSIGNED TO EXAMINER
Wednesday, December 1, 2010NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, November 30, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 27, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceuticals onyx diseases disorders tumors hematological amylodiosis metabolic lupus autoimmune inflammation